-
ANH News Beat (week 37/2023)
13 September 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
Beyond digital addiction: how technologies are transforming our youths into obedient machines
13 September 2023
In this article we explore the impact of digital technology on young people, the dangers of Big Tech’s game plan and we offer you a short but insightful conversation with behaviour and communications expert, David Charalambous, on the mechanisms of manipulation but also the solutions for creating a better future
-
Pathfinder Members' Briefing and Q&A - July 2023
13 July 2023
Zoom recording of July's Pathfinder members' briefing and Q&A
-
Pathfinder Members' Briefing and Q&A - July 2023
13 July 2023
Zoom recording of July's Pathfinder members' briefing and Q&A
-
ANH News Beat (week 27/2023)
06 July 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
The new dawn of mRNA technology
11 May 2023
Republishing article by Rob Verkerk PhD for Dr Ron Hoffman's Intelligent Medicine: Cancer patients look to be next in line for experimental mRNA shots
News / ANH Covid Zone / Health / Campaigns
-
The plan for WHO supremacy over human health
11 May 2023
Extreme risks posed by the International Health Regulations amendments and the WHO ‘Pandemic Treaty’ – and what we can do about them
News / ANH Covid Zone / Health / Campaigns
-
Rob Verkerk to lead ANH both sides of the Atlantic
13 April 2023
With challenges to natural health and freedom mounting in the USA, the UK and Europe, ANH USA and International teams consolidate, with Verkerk as leader
-
How the UK Government failed its public
05 May 2023
In an open letter to UK PM, psychotherapist Christian Buckland PsychD, exposes unethical manipulation and denial of informed consent during covid era
News / ANH Covid Zone / Health / Activism
-
Are you up for taking Big Pharma's new 'skinny' jab?
16 March 2023
After a succession of Big Pharma failures for anti-obesity drugs, will Novo Nordisk's latest offering, that emerges from something of a dark cloud, be just another side effect ladened sticking plaster, or a boon for users and a cash cow for its manufacturer?